Literature DB >> 9188059

Swelling of and drug release from monoglyceride-based drug delivery systems.

C M Chang1, R Bodmeier.   

Abstract

Depending on the water content, unsaturated monoglycerides form various liquid crystalline phases, which can be used as sustained-release carriers. The aim of this study was to investigate the water uptake of and drug release from melt-congealed monoglyceride-based drug carriers. The water uptake of the unsaturated monoglycerides monoolein and monolinolein followed second-order swelling kinetics and levelled off at about 50% water content, at which a highly viscous cubic phase was formed. The rapid formation of the cubic phase suggested that the drug release occurred mainly from this phase. The drug release followed the square-root of time relationship during the initial release phase. Chlorpheniramine maleate, an amphiphilic drug was not completely released because of binding to the cubic phase. The rate of water uptake increased and the maximum water uptake decreased with increasing temperature. The drug release could be controlled by varying the surface-to-volume ratio, the drug loading, and the water content of the lipid matrix. It was independent of the source of monoolein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188059     DOI: 10.1021/js960256w

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.

Authors:  Eder André Estracanholli; Fabíola Silva Garcia Praça; Ana Beatriz Cintra; Maria Bernadete Riemma Pierre; Marilisa Guimarães Lara
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

2.  Phytantriol-based in situ liquid crystals with long-term release for intra-articular administration.

Authors:  Yulin Chen; Xin Liang; Ping Ma; Yaotian Tao; Xiaoqing Wu; Xingxing Wu; Xiaoqing Chu; Shuangying Gui
Journal:  AAPS PharmSciTech       Date:  2015-01-09       Impact factor: 3.246

3.  Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.

Authors:  Zhiwen Yang; Yinhe Tan; Meiwan Chen; Linghui Dian; Ziyun Shan; Xinsheng Peng; Chuanbin Wu
Journal:  AAPS PharmSciTech       Date:  2012-10-23       Impact factor: 3.246

4.  Evaluation of an acetic acid ester of monoglyceride as a suppository base with unique properties.

Authors:  A K Dash; G C Cudworth
Journal:  AAPS PharmSciTech       Date:  2001-07-17       Impact factor: 3.246

5.  Mapping the Impact of a Polar Aprotic Solvent on the Microstructure and Dynamic Phase Transition in Glycerol Monooleate/Oleic Acid Systems.

Authors:  Marzuka Shoeb Kazi; Mohammed Hassan Dehghan
Journal:  Turk J Pharm Sci       Date:  2020-06-22

6.  Ciprofloxacin monoolein water gels as implants for the treatment of chronic osteomyelitis: In vitro characterization.

Authors:  Bavouma Charles Sombié; Josias Gérard Yameogo; Rasmané Semdé; Viviane Henschel; Karim Amighi; Jonathan Goole
Journal:  J Adv Pharm Technol Res       Date:  2014-10

7.  Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers.

Authors:  Pataranapa Nimtrakul; Pakawadee Sermsappasuk; Waree Tiyaboonchai
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

8.  Effect of hydroxyapatite on the physicochemical characteristics of a gentamicin-loaded monoolein gel intended to treat chronic osteomyelitis.

Authors:  Rasmané Semdé; Réné Flore Gueu Gondi; Bavouma Charles Sombié; B Gérard Josias Yaméogo; Moustapha Ouédraogo
Journal:  J Adv Pharm Technol Res       Date:  2012-04

9.  In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.

Authors:  Mohamed Nasr; Mohamed K Ghorab; Ahmed Abdelazem
Journal:  Acta Pharm Sin B       Date:  2014-12-29       Impact factor: 11.413

Review 10.  Cubic and hexagonal liquid crystals as drug delivery systems.

Authors:  Yulin Chen; Ping Ma; Shuangying Gui
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.